Fig. 3From: The phospholipase D inhibitor FIPI potently blocks EGF-induced calcium signaling in human breast cancer cellsFIPI has no impact on the expression and phosphorylation levels of RTKs and signal transduction molecules. MDA-NEO cells (a, c) and MDA-HER2 cells (b, d) were pretreated with 100Â nM FIPI as indicated and then stimulated with 100Â ng/ml EGF. Representative Western blot data from at least four independent experiments are shownBack to article page